JAZZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Jazz Pharmaceuticals plc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$208.43−1.80 (-0.86%)
Close on Oct 19, 2026
- Market cap
- $14.47B
- P/E (TTM)
- 14.3
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
99.2%
64M of 65M shares
Institutional holders
643
133 new, 56 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
0 buys · 57 sales
Net sold $67.96M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 5,872,123 | 9.50% | 13G (passive) amendment | Sep 30, 2024 |
| FMR LLC | 4,675,459 | 7.40% | 13G (passive) | Jun 30, 2026 |
| Vanguard Capital Management | 3,103,522 | 5.04% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of JAZZ | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,968,603 | 9.19% | $1.44B | +376,903 | 0.02% |
| FMR LLC | 4,609,326 | 7.10% | $1.11B | +2,333,564 | 0.05% |
| Vanguard Portfolio Management LLC | 3,036,213 | 4.68% | $731.64M | +52,971 | 0.03% |
| Vanguard Capital Management LLC | 2,729,650 | 4.20% | $657.76M | +81,317 | 0.01% |
| Capital World Investors | 2,697,610 | 4.16% | $650.04M | +24,234 | 0.08% |
| Lsv Asset Management | 2,275,145 | 3.50% | $548.24K | −111,695 | 0.99% |
| Franklin Resources Inc | 2,040,250 | 3.14% | $491.64M | +81,310 | 0.11% |
| State Street Corp | 1,999,816 | 3.08% | $481.90M | +108,170 | 0.01% |
| Dimensional Fund Advisors LP | 1,713,592 | 2.64% | $412.91M | −181,623 | 0.07% |
| Fuller & Thaler Asset Management, Inc. | 1,638,544 | 2.52% | $394.84M | −37,598 | 1.08% |
| Bank of New York Mellon Corp | 1,578,013 | 2.43% | $380.25M | −101,358 | 0.06% |
| Aqr Capital Management LLC | 1,522,568 | 2.35% | $359.94M | +184,110 | 0.13% |
| Geode Capital Management, LLC | 1,483,031 | 2.28% | $357.44M | +245,414 | 0.02% |
| Ameriprise Financial Inc | 1,215,523 | 1.87% | $292.90M | −392,953 | 0.06% |
| JPMorgan Chase & Co | 1,160,786 | 1.79% | $276.63M | −43,567 | 0.02% |
| Bank Of America Corp /De/ | 1,136,091 | 1.75% | $273.76M | +121,291 | 0.02% |
| Citadel Advisors LLC | 1,006,676 | 1.55% | $242.58M | −252,768 | 0.03% |
| Swedbank AB | 968,092 | 1.49% | $233.28M | −24,016 | 0.20% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 799,297 | 1.23% | $192.61M | −85,904 | 0.19% |
| Millennium Management LLC | 763,880 | 1.18% | $184.07M | −498,631 | 0.07% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 643 | 64M | 99.2% | 133 / 241 | 188 / 56 | 9M | 10M |
| Q1 2026 | 575 | 65M | 100.0% | 92 / 226 | 163 / 79 | 15M | 7M |
| Q4 2025 | 574 | 63M | 97.7% | 129 / 179 | 195 / 51 | 10M | 10M |
| Q3 2025 | 503 | 63M | 96.5% | 61 / 163 | 200 / 53 | 7M | 6M |
| Q2 2025 | 502 | 62M | 95.8% | 60 / 188 | 179 / 103 | 9M | 6M |
| Q1 2025 | 550 | 59M | 90.9% | 100 / 218 | 157 / 52 | 8M | 7M |
| Q4 2024 | 509 | 59M | 91.2% | 92 / 169 | 173 / 56 | 6M | 6M |
| Q3 2024 | 478 | 59M | 91.4% | 77 / 164 | 159 / 50 | 12M | 6M |
| Q2 2024 | 456 | 59M | 91.0% | 62 / 160 | 165 / 83 | 8M | 10M |
| Q1 2024 | 481 | 61M | 94.5% | 53 / 184 | 160 / 67 | 9M | 7M |
| Q4 2023 | 500 | 59M | 91.4% | 79 / 166 | 179 / 58 | 9M | 6M |
| Q3 2023 | 485 | 57M | 87.2% | 62 / 163 | 178 / 43 | 4M | 4M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of JAZZ | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,892,522 | 2.92% | $456.04M | 0.02% | Jun 30, 2026 |
| Fullerthaler Behavioral Small Cap Equity | 1,561,563 | 2.41% | $376.29M | 2.97% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 1,366,767 | 2.11% | $329.35M | 0.17% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 865,937 | 1.33% | $208.66M | 0.31% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 719,211 | 1.11% | $173.31M | 0.18% | Jun 30, 2026 |
| VictoryShares Free Cash Flow ETF | 469,858 | 0.72% | $113.22M | 1.46% | Jun 30, 2026 |
| Dimensional U.S. Small Cap ETF | 168,574 | 0.26% | $42.63M | 0.28% | Jul 31, 2026 |
| Vanguard Health Care Index Fund | 164,206 | 0.25% | $38.83M | 0.20% | May 31, 2026 |
| iShares U.S. Pharmaceuticals ETF | 163,023 | 0.25% | $39.28M | 3.45% | Jun 30, 2026 |
| Avantis U.S. Large Cap Value ETF | 154,718 | 0.24% | $36.59M | 0.28% | May 31, 2026 |
| Pear tree polaris foreign value fund | 150,306 | 0.23% | $36.22M | 2.42% | Jun 30, 2026 |
| Dimensional U.S. Core Equity 2 ETF | 147,012 | 0.23% | $37.17M | 0.08% | Jul 31, 2026 |
| Vanguard Strategic Equity Fund | 133,819 | 0.21% | $32.25M | 0.27% | Jun 30, 2026 |
| iShares Russell 1000 Value ETF | 133,445 | 0.21% | $32.16M | 0.04% | Jun 30, 2026 |
| Nuveen Mid Cap Value Fund | 127,888 | 0.20% | $32.34M | 1.92% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Neena M. Patil | EVP & Chief Legal Officer | 47,671 | 0.07% | Sep 14, 2026 |
| Renee D. Gala | President & CEO | 143,394 | 0.22% | Sep 10, 2026 |
| Mary Elizabeth Henderson | SVP, Technical Operations | 23,815 | 0.04% | Sep 10, 2026 |
| Robert Iannone | EVP, Global Head of R&D & CMO | 112,107 | 0.17% | Aug 31, 2026 |
| Samantha Pearce | EVP, Chief Commercial Officer | 47,131 | 0.07% | Aug 7, 2026 |
| Philip L. Johnson | EVP & Chief Financial Officer | 56,431 | 0.09% | Jul 2, 2026 |
| Patricia Carr | SVP, Chief Accounting Officer | 6,512 | 0.01% | Mar 9, 2026 |
| Ted W. Love | Director | 2,389 | 0.00% | Sep 2, 2026 |
| Patrick G. Enright | Director | 21,278 | 0.03% | Sep 2, 2026 |
| Patrick Kennedy | Director | 8,292 | 0.01% | Sep 2, 2026 |
| Laura Hamill | Director | 8,524 | 0.01% | Sep 2, 2026 |
| Norbert G. Riedel | Director | 17,553 | 0.03% | Sep 2, 2026 |
| Heather Ann McSharry | Director | 18,199 | 0.03% | Sep 2, 2026 |
| Mark Douglas Smith | Director | 9,579 | 0.01% | Sep 2, 2026 |
| Bruce C. Cozadd | Director | 351,875 | 0.54% | Sep 2, 2026 |
| Jennifer E. Cook | Director | 10,736 | 0.02% | Sep 2, 2026 |
| Rick E. Winningham | Director | 9,480 | 0.01% | Sep 2, 2026 |
| Seamus Mulligan | Director | 1,286,254 | 1.98% | Aug 7, 2026 |
| Kenneth W. O'Keefe | Director | 30,256 | 0.05% | Dec 4, 2025 |
| Anne ORiordan | Director | 16,500 | 0.03% | Aug 11, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Neena M. Patil EVP & Chief Legal Officer | Sep 10, 2026 | Sale(10b5-1 plan) | −1,200 | $240.94 | $289.13K | 47,671 |
| Mary Elizabeth Henderson SVP, Technical Operations | Sep 8, 2026 | Tax withholding | −15 | $241.20 | $3.62K | 23,815 |
| Mary Elizabeth Henderson SVP, Technical Operations | Sep 8, 2026 | Tax withholding | −1,412 | $243.03 | $343.16K | 23,830 |
| Renee D. Gala President & CEO | Sep 8, 2026 | Sale(10b5-1 plan) | −2,000 | $243.03 | $486.06K | 143,394 |
| Renee D. Gala President & CEO | Sep 8, 2026 | Tax withholding | −1,967 | $246.81 | $485.48K | 145,394 |
| Bruce C. Cozadd Director | Sep 1, 2026 | Sale(10b5-1 plan) | −6,000 | $250.13 | $1.50M | 351,875 |
| Mark Douglas Smith Director | Aug 31, 2026 | Tax withholding | −1,692 | $241.39 | $408.43K | 9,579 |
| Mark Douglas Smith Director | Aug 31, 2026 | Tax withholding | −14 | $244.64 | $3.42K | 11,271 |
| Ted W. Love Director | Aug 31, 2026 | Tax withholding | −737 | $241.39 | $177.90K | 2,389 |
| Ted W. Love Director | Aug 31, 2026 | Tax withholding | −6 | $244.06 | $1.46K | 3,126 |
| Rick E. Winningham Director | Aug 31, 2026 | Tax withholding | −1,692 | $241.39 | $408.43K | 9,480 |
| Rick E. Winningham Director | Aug 31, 2026 | Tax withholding | −14 | $244.64 | $3.42K | 9,466 |
| Mary Elizabeth Henderson SVP, Technical Operations | Aug 31, 2026 | Tax withholding | −16 | $244.64 | $3.91K | 25,242 |
| Mary Elizabeth Henderson SVP, Technical Operations | Aug 31, 2026 | Tax withholding | −2,076 | $241.39 | $501.13K | 25,258 |
| Bruce C. Cozadd Director | Aug 31, 2026 | Tax withholding | −1,209 | $241.39 | $291.84K | 357,875 |
| Bruce C. Cozadd Director | Aug 31, 2026 | Tax withholding | −10 | $244.06 | $2.44K | 359,084 |
| Patrick Kennedy Director | Aug 31, 2026 | Tax withholding | −15 | $244.06 | $3.66K | 8,292 |
| Patrick Kennedy Director | Aug 31, 2026 | Tax withholding | −1,840 | $241.39 | $444.16K | 6,452 |
| Jennifer E. Cook Director | Aug 31, 2026 | Tax withholding | −1,692 | $241.39 | $408.43K | 10,736 |
| Jennifer E. Cook Director | Aug 31, 2026 | Tax withholding | −14 | $244.06 | $3.42K | 12,428 |
| Patrick G. Enright Director | Aug 31, 2026 | Tax withholding | −1,692 | $241.39 | $408.43K | 21,278 |
| Patrick G. Enright Director | Aug 31, 2026 | Tax withholding | −14 | $244.64 | $3.42K | 22,970 |
| Laura Hamill Director | Aug 31, 2026 | Tax withholding | −14 | $244.06 | $3.42K | 8,524 |
| Laura Hamill Director | Aug 31, 2026 | Tax withholding | −1,692 | $241.39 | $408.43K | 6,832 |
| Norbert G. Riedel Director | Aug 31, 2026 | Tax withholding | −1,692 | $241.39 | $408.43K | 6,923 |
| Norbert G. Riedel Director | Aug 31, 2026 | Tax withholding | −14 | $244.64 | $3.42K | 8,615 |
| Heather Ann McSharry Director | Aug 31, 2026 | Tax withholding | −1,840 | $241.39 | $444.16K | 18,199 |
| Heather Ann McSharry Director | Aug 31, 2026 | Tax withholding | −15 | $244.64 | $3.67K | 20,039 |
| Robert Iannone EVP, Global Head of R&D & CMO | Aug 27, 2026 | Option exercise | +884 | $113.10 | $99.98K | 112,107 |
| Robert Iannone EVP, Global Head of R&D & CMO | Aug 27, 2026 | Option exercise | +26,116 | $113.10 | $2.95M | 111,223 |
| Robert Iannone EVP, Global Head of R&D & CMO | Aug 27, 2026 | Sale(10b5-1 plan) | −19,639 | $250.60 | $4.92M | 75,245 |
| Robert Iannone EVP, Global Head of R&D & CMO | Aug 27, 2026 | Sale(10b5-1 plan) | −300 | $252.76 | $75.83K | 65,686 |
| Robert Iannone EVP, Global Head of R&D & CMO | Aug 27, 2026 | Sale(10b5-1 plan) | −9,259 | $251.95 | $2.33M | 65,986 |
| Robert Iannone EVP, Global Head of R&D & CMO | Aug 27, 2026 | Sale(10b5-1 plan) | −18,113 | $250.02 | $4.53M | 94,884 |
| Robert Iannone EVP, Global Head of R&D & CMO | Aug 27, 2026 | Sale(10b5-1 plan) | −11,423 | $248.67 | $2.84M | 112,997 |
| Robert Iannone EVP, Global Head of R&D & CMO | Aug 27, 2026 | Sale(10b5-1 plan) | −18,187 | $247.86 | $4.51M | 124,420 |
| Robert Iannone EVP, Global Head of R&D & CMO | Aug 27, 2026 | Option exercise | +2,916 | $137.12 | $399.84K | 142,607 |
| Robert Iannone EVP, Global Head of R&D & CMO | Aug 27, 2026 | Option exercise | +27,584 | $137.12 | $3.78M | 139,691 |
| Bruce C. Cozadd Director | Aug 5, 2026 | Award | +1,605 | – | – | 362,287 |
| Seamus Mulligan Director | Aug 5, 2026 | Award | +1,605 | – | – | 1,184,633 |
| Mark Douglas Smith Director | Aug 5, 2026 | Award | +1,605 | – | – | 11,285 |
| Heather Ann McSharry Director | Aug 5, 2026 | Award | +1,605 | – | – | 20,054 |
| Norbert G. Riedel Director | Aug 5, 2026 | Award | +1,605 | – | – | 8,629 |
| Laura Hamill Director | Aug 5, 2026 | Award | +1,605 | – | – | 8,538 |
| Patrick Kennedy Director | Aug 5, 2026 | Award | +1,605 | – | – | 8,307 |
| Ted W. Love Director | Aug 5, 2026 | Award | +1,605 | – | – | 3,132 |
| Patrick G. Enright Director | Aug 5, 2026 | Award | +1,605 | – | – | 22,984 |
| Rick E. Winningham Director | Aug 5, 2026 | Award | +1,605 | – | – | 11,172 |
| Jennifer E. Cook Director | Aug 5, 2026 | Award | +1,605 | – | – | 12,442 |
| Samantha Pearce EVP, Chief Commercial Officer | Aug 5, 2026 | Tax withholding | −780 | $261.62 | $204.06K | 47,131 |
| Bruce C. Cozadd Director | Aug 3, 2026 | Sale(10b5-1 plan) | −6,000 | $252.98 | $1.52M | 360,682 |
| Bruce C. Cozadd Director | Jul 1, 2026 | Sale(10b5-1 plan) | −6,000 | $240.47 | $1.44M | 366,682 |
| Renee D. Gala President & CEO | Jun 30, 2026 | Tax withholding | −4,835 | $237.72 | $1.15M | 147,361 |
| Samantha Pearce EVP, Chief Commercial Officer | Jun 30, 2026 | Tax withholding | −2,527 | $237.72 | $600.72K | 47,911 |
| Philip L. Johnson EVP & Chief Financial Officer | Jun 30, 2026 | Tax withholding | −3,343 | $237.72 | $794.70K | 56,431 |
| Neena M. Patil EVP & Chief Legal Officer | Jun 30, 2026 | Tax withholding | −2,678 | $237.72 | $636.61K | 48,871 |
| Robert Iannone EVP, Global Head of R&D & CMO | Jun 30, 2026 | Tax withholding | −3,764 | $237.72 | $894.78K | 85,107 |
| Mark Douglas Smith Director | Jun 15, 2026 | Sale(10b5-1 plan) | −1,157 | $230.55 | $266.75K | 9,680 |
| Neena M. Patil EVP & Chief Legal Officer | Jun 10, 2026 | Sale(10b5-1 plan) | −1,200 | $231.83 | $278.20K | 51,549 |
| Renee D. Gala President & CEO | Jun 3, 2026 | Gift | −600 | – | – | 152,196 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| O'Riordan Anne Director | Oct 8, 2026 | 14,687 | $3.36M | Oct 8, 2026 | Stock Option Exercise |
| D. Gala Renee Officer | Oct 6, 2026 | 2,000 | $472.80K | Oct 6, 2026 | Restricted Stock |
| C. Cozadd Bruce Officer | Oct 1, 2026 | 6,000 | $1.38M | Oct 1, 2026 | Stock Option |
| Patil Neena Officer | Sep 10, 2026 | 1,200 | $289.13K | Sep 10, 2026 | Restricted Stock |
| D. Gala Renee Officer | Sep 8, 2026 | 2,000 | $486.06K | Sep 8, 2026 | Restricted Stock |
| Mary Elizabeth Henderson Director | Sep 8, 2026 | 2,691 | $664.17K | Sep 8, 2026 | RESTRICTED STOCK VESTING |
| C. Cozadd Bruce Officer | Sep 1, 2026 | 6,000 | $1.50M | Sep 1, 2026 | Stock Option |
| Jennifer E. Cook Director | Aug 31, 2026 | 3,507 | $857.60K | Aug 31, 2026 | RESTRICTED STOCK VESTING |
| Heather Ann McSharry Director | Aug 31, 2026 | 3,507 | $857.60K | Aug 31, 2026 | RESTRICTED STOCK VESTING |
| Bruce C. Cozadd Director | Aug 31, 2026 | 2,506 | $612.82K | Aug 31, 2026 | RESTRICTED STOCK VESTING |
| Ted W. Love Director | Aug 31, 2026 | 1,527 | $373.41K | Aug 31, 2026 | RESTRICTED STOCK VESTING |
| Rick E. Winningham Director | Aug 31, 2026 | 3,507 | $857.60K | Aug 31, 2026 | RESTRICTED STOCK VESTING |
| Patrick Kennedy Director | Aug 31, 2026 | 3,507 | $857.60K | Aug 31, 2026 | RESTRICTED STOCK VESTING |
| Patrick G. Enright Director | Aug 31, 2026 | 3,507 | $857.60K | Aug 31, 2026 | RESTRICTED STOCK VESTING |
| Norbert G. Riedel Director | Aug 31, 2026 | 3,507 | $857.60K | Aug 31, 2026 | RESTRICTED STOCK VESTING |